*This response is based on the best information available as of 12/16/21. descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work authorized with an express license from the American Hospital Association. of the Medicare program. Gout arthritis and joint inflammation are linked due to the fact that several way of living aspects, such as excess weight, high blood pressure, bad diet and absence of exercise, can bring about the growth of the joint problem. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. Copyright 2020 TLD Systems. 2) Try using the MCD Search and enter your information in the "Enter keyword, code, or document ID" box. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81328. Coding Drmikethecoder special: Have 5 dates of service audited for $250 (new clients only). *Dual diagnosis requirement: ICD-10 code B18.0, B18.1, or B18.2 must be reported with ICD-10 code K76.9 to indicate compensated liver disease. You are using an out of date browser. ONLY IF NO MORE DESCRIPTIVE MODIFIER IS AVAILABLE, AND THE USE OF MODIFIER -59 BEST EXPLAINS THE CIRCUMSTANCES, SHOULD MODIFIER -59 BE USED. Cpt You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. Tophi are a symptom of gout, a condition where uric acid crystallizes in joints like Please do not use this feature to contact CMS. The AMA assumes no liability for data contained or not contained herein. We NEVER sell or give your information to anyone. *Dual diagnosis requirement: ICD-10 code F52.0 must be reported with ICD-10 code N95.8. If you are looking for a specific code, use your browser's Find function (Ctrl-F) to quickly locate the code in the article. Applicable FARS/HHSARS apply. It may not display this or other websites correctly. Abrocitnib, mavacamten and belzutifan were added to Table 2 (FDA) for CYP2C19. Sometimes, a large group can make scrolling thru a document unwieldy. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. Copyright © 2022, the American Hospital Association, Chicago, Illinois. Table 2. Article revised and published on 03/09/2023 effective for dates of service on and after 10/26/2022 to update the article from CPIC and FDA sources. CPT 28041 Excision, tumor, soft tissue of foot or toe, subfascial (eg. Intramuscular); 1.5 cm or greater If the soft tissue mass that appeared to be a gouty tophus was located in the ankle on the lateral aspect, clearly it would be affecting the joint. The most appropriate CPT code to consider would be the following: No. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). *Dual diagnosis requirement: ICD-10 code C34.90 must be reported with ICD-10 code Z92.21 to identify personal history of antineoplastic chemotherapy. Current CPIC guidelines as of October 26, 2022: PPIs (class): omeprazole, lansoprazole, pantoprazole, dexlansoprazole, SSRIs (class): citalopram, escitalopram, fluvoxamine, paroxetine, sertraline, Tricyclic antidepressants (class): amitriptyline, clomipramine, desipramine, doxepin, imipramine, nortriptyline, trimipramine, Anafranil, Norpramin, Silenor,Pamelor, Surmontil, NSAIDs (class): celecoxib, flurbiprofen, ibuprofen, lornoxicam, meloxicam, piroxicam, tenoxicam, Celebrex, Ocufen, Chlortenoxicam, Mobic, Feldene, Mobiflex, abacavir, allopurinol, oxcarbazepine, phenytoin, carbamazepine, fosphenytoin, Ziagen, Zyloprim, Aloprim, Trileptal, Oxtellar, Dilantin, Tegretol, Cerebyx, 81226, 81418, 0070U, 0071U, 0072U, 0073U, 0074U, 0075U, 0076U, atomoxetine, codeine, ondansetron, tropisetron, tamoxifen, tramadol, hydrocodone, Fluoropyrimidines (class): fluorouracil, capecitabine, dapsone, methylene blue, nitrofurantoin, pegloticase, primaquine, tafenoquine, Aczone, Provayblue, Furadantin, Macrobid, Macrodantin, Krystexxa, Primaquine, Arakoda, Krintafel, peginterferon alfa-2a, peginterferon alfa-2b, Volatile anesthetics (class): desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane, succinylcholine, Suprane, Ethrane, Fluothane, Forane, Penthrox, Ultane, Anectine, Quelicin, Statins (class): simvastatin, pravastatin, atorvastatin, lovastatin, rosuvastatin, fluvastatin, pitavastatin, Zocor, FloLipid, Pravachol, Lipitor, Altoprev, Crestor, Lescol, Livalo, Thiopurines (class): mercaptopurine, azathioprine, thioguanine, Aminoglycosides (class): gentamicin, amikacin, paromomycin, streptomycin, plazomicin, tobramycin. MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. The list of results will include documents which contain the code you entered. CFR, Title 42, Volume 3, Chapter IV, Part 414.50 Physician or other supplier billing for diagnostic tests performed or interpreted by a physician who does not share a practice with the billing physician or other supplier. *Dual diagnosis requirement: ICD-10 code C43.0, C43.111, C43.112, C43.121, C43.122, C43.21, C43.22, C43.31, C43.39, C43.4, C43.51, C43.52, C43.59, C43.61, C43.62, C43.71, C43.72, C43.8 or C43.9 must be reported with ICD-10 code C77.9 to indicate nodal involvement. An official website of the United States government. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. Revenue Codes are equally subject to this coverage determination. Excision subcutaneous soft tissue tumor; upper arm or elbow (24075) Excision, tumor, upper arm or elbow area; deep, subfascial DISCLOSED HEREIN. Enjoy a guided tour of FindACode's many features and tools. Article revised and published on 08/04/2022 in response to an inquiry to update the article from CPIC and FDA sources. If the soft tissue mass was not located within the ankle, the appropriate CPT codes to consider are the following: CPT 27618 Excision, tumor, soft tissue of leg or ankle area; subcutaneous; less than 3 cm, CPT 27619 Excision, tumor, soft tissue of leg or ankle area; subfascial (e.g. CDT is a trademark of the ADA. The contractor information can be found at the top of the document in the, Please use the Reset Search Data function, found in the top menu under the Settings (gear) icon. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. Report code 81479 and gene test IFNL4 in the claim narrative/remarks. Review the article, in particular the Coding Information section. Dissection or elevation of tissue planes to permit resection of the tumor is included in the excision and not separately reported. Radical resection of soft connective tissue tumors involves the resection of the tumor with wide margins of normal tissue. The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be This is the American ICD-10-CM version of M10.041 - other international versions of ICD-10 M10.041 may differ. Neither the United States Government nor its employees represent that use of such information, product, or processes CPT code 81418 was added to Table 1 (CPIC) and Table 2 (FDA) for genes CYP2C19 and CYP2D6. Clinicians who order germline testing may wish to be aware of whether the test that they are ordering is covered under Medicare and may wish to verify that they are not ordering repeat germline testing. CMS and its products and services are not endorsed by the AHA or any of its affiliates. Cardiothoracic SurgeryDiagnostic & Interventional CardiovascularDiagnostic RadiologyInterventional RadiologyPain ManagementVascular & Endovascular Surgery. If you dont find the Article you are looking for, contact your MAC. No, he does not say that he has gone into the joint, but says that upon incision gouty tissue was immediately encountered from the PIP joint and was removed by rongeur and scissors. The only other alternatives seem to be 26115, 26210 or debridement. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. CPT coding guidelines are clear that excision of benign lesions of cutaneous origin, such as a sebaceous cyst, should be reported using codes Tophi removal involves the removal of the painful, infected, or swollen growths. Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. Please visit the. Once tophus had been debrided and cultures taken, wound was irrigated, etc" Because he doesn't document removing bone I'm thinking 26116 (reasoning, he went to bone so it would have to be subfascial). You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. There are different article types: Articles are often related to an LCD, and the relationship can be seen in the "Associated Documents" section of the Article or the LCD. CRs are not policy, rather CRs are used to relay instructions regarding the edits of the various claims processing systems in very descriptive, technical language usually employing the codes or code combinations likely to be encountered with claims subject to the policy in question. An asterisk note has also been added to ICD-10-CM Code Group 4 for ICD-10 code R11.2*. I don't see the code (26808) you wrote - but I guess I'd lean towards 28092 with the info you've given. The AHA Coding Clinic for HCPCS includes: Thank you for choosing Find-A-Code, please Sign In to remove ads. "JavaScript" disabled. Excision CPT Codes - eatonhand.com The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: Group 7 Medical Necessity ICD-10-CM Codes Asterisk Explanation. I had "toe" in my head! WebDeep Soft Tissue Tumor excision CPT Codes. Is it appropriate to report the excision of soft tissue codes in the musculoskeletal system subsection for lesions or tumors that are cutaneous in origin? However, some of the coders feel this procedure should be coded to an excision of lesion. *Dual diagnosis requirement: ICD-10 code B48.8 must be reported with ICD-10 code Z16.32. Report code 81479 and gene test CACNA1S in the claim narrative/remarks. WebTophaceous gout is characterised by nodular masses of deposited monosodium urate crystals (MSU) due to untreated or partially treated hyperuricaemia with associated Although these tumors may be confined to a specific layer (for example, subcutaneous or subfascial), radical resection may involve removal of tissue from one or more layers. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). damages arising out of the use of such information, product, or process. These courses are an opportunity to sharpen your coding skills. Download the app via the Apple Store, Google Play, or Amazon. A patient is seen at our facility for an excisional debridement of severe gouty tophi of the left index and long finger of the proximal interphalangeal and distal interphalangeal joints. Applications are available at the American Dental Association web site. *Dual diagnosis requirement: ICD-10-CM code Q85.83 must be billed with ICD-10-CM code C25.4, C64.1, C64.2, C65.1, C65.2, C66.1, C66.2, C67.0, C67.1, C67.2, C67.3, C67.4, C67.5, C67.6, C67.7, C67.8, C68.0, C68.1, C68.8, C7A.093, D13.7, D18.02, D32.0, D32.1, D33.0, D33.1, D33.3, D33.4 OR D33.7. Excision of fascial or subfascial soft tissue tumors involves the resection of tumors confined to the tissue within or below the deep fascia but not involving the bone. intramuscular); less than 1.5 cm. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81231. *Report ICD-10 code C50.919 or C50.929 with ICD-10 code Z17.0 or Z17.1 to identify estrogen receptor status. CPT 28043 Excision, tumor, soft tissue of foot or toe, subcutaneous; less than 1.5 cm MODIFIER -59 IS USED TO IDENTIFY PROCEDURES/SERVICES THAT ARE NOT NORMALLY REPORTED TOGETHER, BUT ARE APPROPRIATE UNDER THE CIRCUMSTANCES. The provider performing the service must have a record of what drug(s) is/are being considered and for what indication to ensure the test performed is medically reasonable and necessary. Surgeon gave MBS number For this supplementary claims processing information we rely on other CMS publications, namely Change Requests (CR) Transmittals and inclusions in the Medicare Fee-For-Service Claims Processing Manual (CPM). The following drugs and associated genes and CPT codes were added to Table 2 (FDA): voriconazole (CYP2C19/81225), fosphenytoin, meloxicam, phenytoin (CYP2C9/81227), oliceridine, pitolisant (CYP2D6/81226, 0070U, 0071U, 0072U, 0073U, 0074U, 0075U, 0076U), fosphenytoin, phenytoin (HLA-B/81381, 81374), and sacituzumab govitecan-hziy (UGT1A1/81350). While every effort has been made to provide accurate and You will find them in the Billing & Coding Articles. Excision of gouty tophi | Safer Care Victoria Billing the 59 modifier may result in a request for medical records.The molecular pathology codes include all analytical services performed during the test (e.g., cell lysis, nucleic acid stabilization, extraction, digestion, amplification, and detection). I am going to query and if he DID remove bone with this my bigger question is, would 26262 be more appropriate than 26236 (CPT Lay describes 26262 "The bone and surrounding tissues are resected."). Are all soft tissue tumor excision codes located in one subsection of the CPT codebook? Germline testing, including panels containing some genetic content already tested in the same Medicare beneficiary, may be considered medically reasonable and necessary if there is established clinical utility in the remaining, non-duplicative genetic components of the test.Coding GuidanceNotice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81479 and Gene Test BCHE. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81232. WebExcision CPT Codes. CPT 28039 Excision, tumor, soft tissue of foot or toe, subcutaneous; 1.5 cm or greater Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "I Accept". For the most part, codes are no longer included in the LCD (policy). Joint sites such as elbow, PIP toe, MIP toe etc. Please review and accept the agreements in order to view Medicare Coverage documents, which may include licensed information and codes. Code of Federal Register (CFR) References. Article revised and published on 01/26/2023 effective for dates of service on and after 01/01/2023 to reflect the Annual HCPCS/CPT Code Updates. CPT 28024 Arthrotomy, including exploration, drainage, or removal of loose or foreign body; interphalangeal joint, If the soft tissue mass was located in the foot and it appeared to a gouty tophus and it was not affecting a joint, the appropriate CPT codes to consider would be the following: If no CPT code is available for the gene(s) being tested, the unlisted molecular pathology procedure code 81479 should be used as indicated below.Utilization ParametersGermline testing may be performed once in a lifetime per beneficiary.Documentation Requirements. Article revised and published on 10/20/2022 effective for dates of service on and after 10/01/2022 to reflect the Annual ICD-10-CM Code Updates. Enter the code you're looking for in the "Enter keyword, code, or document ID" box. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period. without the written consent of the AHA. Tumor size is determined by measuring the greatest diameter of the tumor plus that margin required for complete excision of the tumor. *Dual diagnosis requirement: ICD-10 code R11.2 must be reported with ICD-10 code Z48.89, Z51.0 or Z92.21. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81350. The following ICD-10-CM codes support medical necessity and provide coverage for CPT codes: 81226 and 81418. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. No charge. The following CPT codes have been added to the Article: 0286U in Table 1 for Gene/Test NUDT15, Table 2 for Gene NUDT15 and/or TPMT, CPT/HCPCS Codes section for Group 10 Codes, and ICD-10-CM Codes that Support Medical Necessity section for Group 10 Paragraph and 0289U, 0290U, 0291U, 0292U, 0293U, and 0294U in the CPT/HCPCS Codes section for Group 22 Codes. You can collapse such groups by clicking on the group header to make navigation easier. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material. Instructions for enabling "JavaScript" can be found here. This column responds to these questions and offers clarity to coding confusion for this set of codes. of every MCD page. The AHA Coding Clinic for HCPCS includes: Thank you for choosing Find-A-Code, please Sign In to remove ads. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81283. Article revised and published on 04/27/2023 effective for dates of service on and after 01/01/2022 to remove CPT codes 0289U through 0294U from the CPT/HCPCS Code Group 25 that were erroneously added in January 2022. Sign up to get the latest information about your choice of CMS topics in your inbox. Many offices across the country consider this to be their Bible when it comes to coding, billing and documentation. Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration All rights reserved. 633 N. Saint Clair St. CPT 27620 Arthrotomy, ankle, with joint exploration, with or without biopsy, with or without removal of loose or foreign body, In the above post, the soft tissue mass is located over the distal fibula and it appeared to be a gouty tophus. If you need more information on coverage, contact the Medicare Administrative Contractor (MAC) who published the document. Excisional debridement of gouty tophi - AHA Coding Yes, for each anatomic family of codes, two codes are available to report excision of subcutaneous soft tissue tumors, two codes for the excision of subfascial soft tissue tumors, and two codes for the radical resection of soft tissue tumors. If that doesnt work please contact, Technical issues include things such as a link is broken, a report fails to run, a page is not displaying correctly, a search is taking an unexpectedly long time to complete. Medicare contractors are required to develop and disseminate Articles. required field. No, he does not say that he has gone into the joint, but says that upon incision gouty tissue was immediately encountered from the PIP joint and was removed by rongeur and scissors. *When reporting ICD-10 codes N39.41 or N39.46, also report ICD-10 code N32.81 for any associated overactive bladder. These materials contain Current Dental Terminology (CDTTM), copyright© 2022 American Dental Association (ADA). If this is your first visit, be sure to check out the. You now have the opportunity to claim CME credit for time spent reading the monthly Bulletin of the American College of Surgeons. The following CPT code has been added to the Article: 81418 in Code Groups 2, 3, and 4. In the above post, the soft tissue mass is located over the distal fibula and it appeared to be a gouty tophus. Article document IDs begin with the letter "A" (e.g., A12345). All those not listed under the ICD-10-CM Codes that Support Medical Necessity section of this article. If the soft tissue mass that appeared to be a gouty tophus was located in the ankle on the lateral aspect, clearly it would be affecting the joint. tophi | Medical Billing and Coding Forum - AAPC Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. CPT code 11044 describes debridement to and including bone. If this is your first visit, be sure to check out the. Gout attacks can last for numerous days and also also months. registered for member area and forum access. Report code 81479 and gene test BCHE in the claim narrative/remarks. The following ICD-10-CM codes were added to the ICD-10-CM Codes that Support Medical Necessity section for Code Group 5: T38.3X5A and for Code Group 8: B51.0, B51.8, B51.9, D74.8, L70.0, M1A.0110, M1A.0111, M1A.0120, M1A.0121, M1A.0210, M1A.0211, M1A.0220, M1A.0221, M1A.0310, M1A.0311, M1A.0320, M1A.0321, M1A.0410, M1A.0411, M1A.0420, M1A.0421, M1A.0510, M1A.0511, M1A.0520, M1A.0521, M1A.0610, M1A.0611, M1A.0620, M1A.0621, M1A.0710, M1A.0711, M1A.0720, M1A.0721, M1A.08X0, M1A.08X1, M1A.09X0, M1A.09X1, M1A.1110, M1A.1111, M1A.1120, M1A.1121, M1A.1210, M1A.1211, M1A.1220, M1A.1221, M1A.1310, M1A.1311, M1A.1320, M1A.1321, M1A.1410, M1A.1411, M1A.1420, M1A.1421, M1A.1510, M1A.1511, M1A.1520, M1A.1521, M1A.1610, M1A.1611, M1A.1620, M1A.1621, M1A.1710, M1A.1711, M1A.1720, M1A.1721, M1A.18X0, M1A.18X1, M1A.19X0, M1A.19X1, M1A.2110, M1A.2111, M1A.2120, M1A.2121, M1A.2210, M1A.2211, M1A.2220, M1A.2221, M1A.2310, M1A.2311, M1A.2320, M1A.2321, M1A.2410, M1A.2411, M1A.2420, M1A.2421, M1A.2510, M1A.2511, M1A.2520, M1A.2521, M1A.2610, M1A.2611, M1A.2620, M1A.2621, M1A.2710, M1A.2711, M1A.2720, M1A.2721, M1A.28X0, M1A.28X1, M1A.29X0, M1A.29X1, M1A.3110, M1A.3111, M1A.3120, M1A.3121, M1A.3210, M1A.3211, M1A.3220, M1A.3221, M1A.3310, M1A.3311, M1A.3320, M1A.3321, M1A.3410, M1A.3411, M1A.3420, M1A.3421, M1A.3510, M1A.3511, M1A.3520, M1A.3521, M1A.3610, M1A.3611, M1A.3620, M1A.3621, M1A.3710, M1A.3711, M1A.3720, M1A.3721, M1A.38X0, M1A.38X1, M1A.39X0, M1A.39X1, M1A.4110, M1A.4111, M1A.4120, M1A.4121, M1A.4210, M1A.4211, M1A.4220, M1A.4221, M1A.4310, M1A.4311, M1A.4320, M1A.4321, M1A.4410, M1A.4411, M1A.4420, M1A.4421, M1A.4510, M1A.4511, M1A.4520, M1A.4521, M1A.4610, M1A.4611, M1A.4620, M1A.4621, M1A.4710, M1A.4711, M1A.4720, M1A.4721, M1A.48X0, M1A.48X1, M1A.49X0, M1A.49X1, N30.00* and N30.01* (with associated asterisk note). Genes assayed on the same date of service are considered to be assayed serially when there is a reflexive decision component where the results of the analysis of one or more genes determines whether the results of additional analyses are medically reasonable and necessary. The following ICD-10-CM codes support medical necessity and provide coverage for CPT code: 81479 and Gene Test CACNA1S. Cystic fibrosis with other manifestations, Malignant neoplasm of right kidney, except renal pelvis, Malignant neoplasm of left kidney, except renal pelvis, Malignant neoplasm of lateral wall of bladder, Malignant neoplasm of anterior wall of bladder, Malignant neoplasm of posterior wall of bladder, Malignant neoplasm of overlapping sites of bladder, Malignant neoplasm of paraurethral glands, Malignant neoplasm of overlapping sites of urinary organs, Benign neoplasm of other specified parts of central nervous system, Multiple endocrine neoplasia [MEN] syndrome, unspecified, Major depressive disorder, single episode, moderate, Major depressive disorder, single episode, severe without psychotic features, Major depressive disorder, single episode, severe with psychotic features, Major depressive disorder, single episode, in partial remission, Major depressive disorder, single episode, unspecified, Major depressive disorder, recurrent, moderate, Major depressive disorder, recurrent severe without psychotic features, Major depressive disorder, recurrent, severe with psychotic symptoms, Major depressive disorder, recurrent, in partial remission, Major depressive disorder, recurrent, unspecified, Panic disorder [episodic paroxysmal anxiety], Obsessive-compulsive personality disorder, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus, Lennox-Gastaut syndrome, not intractable, with status epilepticus, Lennox-Gastaut syndrome, not intractable, without status epilepticus, Lennox-Gastaut syndrome, intractable, with status epilepticus, Lennox-Gastaut syndrome, intractable, without status epilepticus, ST elevation (STEMI) myocardial infarction involving left main coronary artery, ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery, ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall, ST elevation (STEMI) myocardial infarction involving right coronary artery, ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall, ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery, ST elevation (STEMI) myocardial infarction involving other sites, Non-ST elevation (NSTEMI) myocardial infarction, Subsequent ST elevation (STEMI) myocardial infarction of anterior wall, Subsequent ST elevation (STEMI) myocardial infarction of inferior wall, Subsequent non-ST elevation (NSTEMI) myocardial infarction, Subsequent ST elevation (STEMI) myocardial infarction of other sites, Unspecified sequelae of cerebral infarction, Gastro-esophageal reflux disease with esophagitis, without bleeding, Gastro-esophageal reflux disease with esophagitis, with bleeding, Gastro-esophageal reflux disease without esophagitis, Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation, Chronic or unspecified duodenal ulcer with both hemorrhage and perforation, Chronic duodenal ulcer without hemorrhage or perforation, Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits, Malignant neoplasm of unspecified site of unspecified female breast, Malignant neoplasm of unspecified site of unspecified male breast, Attention-deficit hyperactivity disorder, predominantly hyperactive type, Attention-deficit hyperactivity disorder, combined type, Attention-deficit hyperactivity disorder, other type, Malignant neoplasm of unspecified part of unspecified bronchus or lung, Bipolar disorder, current episode hypomanic, Bipolar disorder, current episode manic without psychotic features, mild, Bipolar disorder, current episode manic without psychotic features, moderate, Bipolar disorder, current episode manic without psychotic features, severe, Bipolar disorder, current episode manic severe with psychotic features, Bipolar disorder, current episode depressed, mild, Bipolar disorder, current episode depressed, moderate, Bipolar disorder, current episode depressed, severe, without psychotic features, Bipolar disorder, current episode depressed, severe, with psychotic features, Bipolar disorder, current episode mixed, mild, Bipolar disorder, current episode mixed, moderate, Bipolar disorder, current episode mixed, severe, without psychotic features, Bipolar disorder, current episode mixed, severe, with psychotic features, Bipolar disorder, in partial remission, most recent episode hypomanic, Bipolar disorder, in partial remission, most recent episode manic, Bipolar disorder, in partial remission, most recent episode depressed, Bipolar disorder, in partial remission, most recent episode mixed, Longstanding persistent atrial fibrillation, Unspecified systolic (congestive) heart failure, Unspecified diastolic (congestive) heart failure, Unspecified combined systolic (congestive) and diastolic (congestive) heart failure, Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus, Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus, Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus, Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus, Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus, Atherosclerotic heart disease of native coronary artery without angina pectoris, Other specified rheumatoid arthritis, other specified site, Primary osteoarthritis, other specified site, Secondary osteoarthritis, other specified site, Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter, Encounter for surgical aftercare following surgery on the nervous system, Personal history of other diseases of the circulatory system, Malignant neoplasm of stomach, unspecified, Malignant neoplasm of rectosigmoid junction, Malignant neoplasm of pancreas, unspecified, Plasmodium vivax malaria with rupture of spleen, Plasmodium vivax malaria with other complications, Plasmodium vivax malaria without complication, Disorder of purine and pyrimidine metabolism, unspecified, Idiopathic chronic gout, right shoulder, without tophus (tophi), Idiopathic chronic gout, right shoulder, with tophus (tophi), Idiopathic chronic gout, left shoulder, without tophus (tophi), Idiopathic chronic gout, left shoulder, with tophus (tophi), Idiopathic chronic gout, right elbow, without tophus (tophi), Idiopathic chronic gout, right elbow, with tophus (tophi), Idiopathic chronic gout, left elbow, without tophus (tophi), Idiopathic chronic gout, left elbow, with tophus (tophi), Idiopathic chronic gout, right wrist, without tophus (tophi), Idiopathic chronic gout, right wrist, with tophus (tophi), Idiopathic chronic gout, left wrist, without tophus (tophi), Idiopathic chronic gout, left wrist, with tophus (tophi), Idiopathic chronic gout, right hand, without tophus (tophi), Idiopathic chronic gout, right hand, with tophus (tophi), Idiopathic chronic gout, left hand, without tophus (tophi), Idiopathic chronic gout, left hand, with tophus (tophi), Idiopathic chronic gout, right hip, without tophus (tophi), Idiopathic chronic gout, right hip, with tophus (tophi), Idiopathic chronic gout, left hip, without tophus (tophi), Idiopathic chronic gout, left hip, with tophus (tophi), Idiopathic chronic gout, right knee, without tophus (tophi), Idiopathic chronic gout, right knee, with tophus (tophi), Idiopathic chronic gout, left knee, without tophus (tophi), Idiopathic chronic gout, left knee, with tophus (tophi), Idiopathic chronic gout, right ankle and foot, without tophus (tophi), Idiopathic chronic gout, right ankle and foot, with tophus (tophi), Idiopathic chronic gout, left ankle and foot, without tophus (tophi), Idiopathic chronic gout, left ankle and foot, with tophus (tophi), Idiopathic chronic gout, vertebrae, without tophus (tophi), Idiopathic chronic gout, vertebrae, with tophus (tophi), Idiopathic chronic gout, multiple sites, without tophus (tophi), Idiopathic chronic gout, multiple sites, with tophus (tophi), Lead-induced chronic gout, right shoulder, without tophus (tophi), Lead-induced chronic gout, right shoulder, with tophus (tophi), Lead-induced chronic gout, left shoulder, without tophus (tophi), Lead-induced chronic gout, left shoulder, with tophus (tophi), Lead-induced chronic gout, right elbow, without tophus (tophi), Lead-induced chronic gout, right elbow, with tophus (tophi), Lead-induced chronic gout, left elbow, without tophus (tophi), Lead-induced chronic gout, left elbow, with tophus (tophi), Lead-induced chronic gout, right wrist, without tophus (tophi), Lead-induced chronic gout, right wrist, with tophus (tophi), Lead-induced chronic gout, left wrist, without tophus (tophi), Lead-induced chronic gout, left wrist, with tophus (tophi), Lead-induced chronic gout, right hand, without tophus (tophi), Lead-induced chronic gout, right hand, with tophus (tophi), Lead-induced chronic gout, left hand, without tophus (tophi), Lead-induced chronic gout, left hand, with tophus (tophi), Lead-induced chronic gout, right hip, without tophus (tophi), Lead-induced chronic gout, right hip, with tophus (tophi), Lead-induced chronic gout, left hip, without tophus (tophi), Lead-induced chronic gout, left hip, with tophus (tophi), Lead-induced chronic gout, right knee, without tophus (tophi), Lead-induced chronic gout, right knee, with tophus (tophi), Lead-induced chronic gout, left knee, without tophus (tophi), Lead-induced chronic gout, left knee, with tophus (tophi), Lead-induced chronic gout, right ankle and foot, without tophus (tophi), Lead-induced chronic gout, right ankle and foot, with tophus (tophi), Lead-induced chronic gout, left ankle and foot, without tophus (tophi), Lead-induced chronic gout, left ankle and foot, with tophus (tophi), Lead-induced chronic gout, vertebrae, without tophus (tophi), Lead-induced chronic gout, vertebrae, with tophus (tophi), Lead-induced chronic gout, multiple sites, without tophus (tophi), Lead-induced chronic gout, multiple sites, with tophus (tophi), Drug-induced chronic gout, right shoulder, without tophus (tophi), Drug-induced chronic gout, right shoulder, with tophus (tophi), Drug-induced chronic gout, left shoulder, without tophus (tophi), Drug-induced chronic gout, left shoulder, with tophus (tophi), Drug-induced chronic gout, right elbow, without tophus (tophi), Drug-induced chronic gout, right elbow, with tophus (tophi), Drug-induced chronic gout, left elbow, without tophus (tophi), Drug-induced chronic gout, left elbow, with tophus (tophi), Drug-induced chronic gout, right wrist, without tophus (tophi), Drug-induced chronic gout, right wrist, with tophus (tophi), Drug-induced chronic gout, left wrist, without tophus (tophi), Drug-induced chronic gout, left wrist, with tophus (tophi), Drug-induced chronic gout, right hand, without tophus (tophi), Drug-induced chronic gout, right hand, with tophus (tophi), Drug-induced chronic gout, left hand, without tophus (tophi), Drug-induced chronic gout, left hand, with tophus (tophi), Drug-induced chronic gout, right hip, without tophus (tophi), Drug-induced chronic gout, right hip, with tophus (tophi), Drug-induced chronic gout, left hip, without tophus (tophi), Drug-induced chronic gout, left hip, with tophus (tophi), Drug-induced chronic gout, right knee, without tophus (tophi), Drug-induced chronic gout, right knee, with tophus (tophi), Drug-induced chronic gout, left knee, without tophus (tophi), Drug-induced chronic gout, left knee, with tophus (tophi), Drug-induced chronic gout, right ankle and foot, without tophus (tophi), Drug-induced chronic gout, right ankle and foot, with tophus (tophi), Drug-induced chronic gout, left ankle and foot, without tophus (tophi), Drug-induced chronic gout, left ankle and foot, with tophus (tophi), Drug-induced chronic gout, vertebrae, without tophus (tophi), Drug-induced chronic gout, vertebrae, with tophus (tophi), Drug-induced chronic gout, multiple sites, without tophus (tophi), Drug-induced chronic gout, multiple sites, with tophus (tophi), Chronic gout due to renal impairment, right shoulder, without tophus (tophi), Chronic gout due to renal impairment, right shoulder, with tophus (tophi), Chronic gout due to renal impairment, left shoulder, without tophus (tophi), Chronic gout due to renal impairment, left shoulder, with tophus (tophi), Chronic gout due to renal impairment, right elbow, without tophus (tophi), Chronic gout due to renal impairment, right elbow, with tophus (tophi), Chronic gout due to renal impairment, left elbow, without tophus (tophi), Chronic gout due to renal impairment, left elbow, with tophus (tophi), Chronic gout due to renal impairment, right wrist, without tophus (tophi), Chronic gout due to renal impairment, right wrist, with tophus (tophi), Chronic gout due to renal impairment, left wrist, without tophus (tophi), Chronic gout due to renal impairment, left wrist, with tophus (tophi), Chronic gout due to renal impairment, right hand, without tophus (tophi), Chronic gout due to renal impairment, right hand, with tophus (tophi), Chronic gout due to renal impairment, left hand, without tophus (tophi), Chronic gout due to renal impairment, left hand, with tophus (tophi), Chronic gout due to renal impairment, right hip, without tophus (tophi), Chronic gout due to renal impairment, right hip, with tophus (tophi), Chronic gout due to renal impairment, left hip, without tophus (tophi), Chronic gout due to renal impairment, left hip, with tophus (tophi), Chronic gout due to renal impairment, right knee, without tophus (tophi), Chronic gout due to renal impairment, right knee, with tophus (tophi), Chronic gout due to renal impairment, left knee, without tophus (tophi), Chronic gout due to renal impairment, left knee, with tophus (tophi), Chronic gout due to renal impairment, right ankle and foot, without tophus (tophi), Chronic gout due to renal impairment, right ankle and foot, with tophus (tophi), Chronic gout due to renal impairment, left ankle and foot, without tophus (tophi), Chronic gout due to renal impairment, left ankle and foot, with tophus (tophi), Chronic gout due to renal impairment, vertebrae, without tophus (tophi), Chronic gout due to renal impairment, vertebrae, with tophus (tophi), Chronic gout due to renal impairment, multiple sites, without tophus (tophi), Chronic gout due to renal impairment, multiple sites, with tophus (tophi), Other secondary chronic gout, right shoulder, without tophus (tophi), Other secondary chronic gout, right shoulder, with tophus (tophi), Other secondary chronic gout, left shoulder, without tophus (tophi), Other secondary chronic gout, left shoulder, with tophus (tophi), Other secondary chronic gout, right elbow, without tophus (tophi), Other secondary chronic gout, right elbow, with tophus (tophi), Other secondary chronic gout, left elbow, without tophus (tophi), Other secondary chronic gout, left elbow, with tophus (tophi), Other secondary chronic gout, right wrist, without tophus (tophi), Other secondary chronic gout, right wrist, with tophus (tophi), Other secondary chronic gout, left wrist, without tophus (tophi), Other secondary chronic gout, left wrist, with tophus (tophi), Other secondary chronic gout, right hand, without tophus (tophi), Other secondary chronic gout, right hand, with tophus (tophi), Other secondary chronic gout, left hand, without tophus (tophi), Other secondary chronic gout, left hand, with tophus (tophi), Other secondary chronic gout, right hip, without tophus (tophi), Other secondary chronic gout, right hip, with tophus (tophi), Other secondary chronic gout, left hip, without tophus (tophi), Other secondary chronic gout, left hip, with tophus (tophi), Other secondary chronic gout, right knee, without tophus (tophi), Other secondary chronic gout, right knee, with tophus (tophi), Other secondary chronic gout, left knee, without tophus (tophi), Other secondary chronic gout, left knee, with tophus (tophi), Other secondary chronic gout, right ankle and foot, without tophus (tophi), Other secondary chronic gout, right ankle and foot, with tophus (tophi), Other secondary chronic gout, left ankle and foot, without tophus (tophi), Other secondary chronic gout, left ankle and foot, with tophus (tophi), Other secondary chronic gout, vertebrae, without tophus (tophi), Other secondary chronic gout, vertebrae, with tophus (tophi), Other secondary chronic gout, multiple sites, without tophus (tophi), Other secondary chronic gout, multiple sites, with tophus (tophi), Chronic viral hepatitis B with delta-agent, Chronic viral hepatitis B without delta-agent, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of other parts of face, Malignant melanoma of other part of trunk, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Malignant melanoma of overlapping sites of skin, Acute lymphoblastic leukemia not having achieved remission, Acute lymphoblastic leukemia, in remission, Acute myeloblastic leukemia, not having achieved remission, Acute myeloblastic leukemia, in remission, Other specified rheumatoid arthritis, multiple sites, Type 2 diabetes mellitus with unspecified complications, Type 2 diabetes mellitus without complications, Personal history of other endocrine, nutritional and metabolic disease, Human immunodeficiency virus [HIV] disease, Malignant neoplasm of connective and soft tissue, unspecified, Malignant neoplasm of nipple and areola, right female breast, Malignant neoplasm of nipple and areola, left female breast, Malignant neoplasm of nipple and areola, right male breast, Malignant neoplasm of nipple and areola, left male breast, Malignant neoplasm of central portion of right female breast, Malignant neoplasm of central portion of left female breast, Malignant neoplasm of central portion of right male breast, Malignant neoplasm of central portion of left male breast, Malignant neoplasm of upper-inner quadrant of right female breast, Malignant neoplasm of upper-inner quadrant of left female breast, Malignant neoplasm of upper-inner quadrant of right male breast, Malignant neoplasm of upper-inner quadrant of left male breast, Malignant neoplasm of lower-inner quadrant of right female breast, Malignant neoplasm of lower-inner quadrant of left female breast, Malignant neoplasm of lower-inner quadrant of right male breast, Malignant neoplasm of lower-inner quadrant of left male breast, Malignant neoplasm of upper-outer quadrant of right female breast, Malignant neoplasm of upper-outer quadrant of left female breast, Malignant neoplasm of upper-outer quadrant of right male breast, Malignant neoplasm of upper-outer quadrant of left male breast, Malignant neoplasm of lower-outer quadrant of right female breast, Malignant neoplasm of lower-outer quadrant of left female breast, Malignant neoplasm of lower-outer quadrant of right male breast, Malignant neoplasm of lower-outer quadrant of left male breast, Malignant neoplasm of axillary tail of right female breast, Malignant neoplasm of axillary tail of left female breast, Malignant neoplasm of axillary tail of right male breast, Malignant neoplasm of axillary tail of left male breast, Malignant neoplasm of overlapping sites of right female breast, Malignant neoplasm of overlapping sites of left female breast, Malignant neoplasm of overlapping sites of right male breast, Malignant neoplasm of overlapping sites of left male breast, Malignant neoplasm of unspecified kidney, except renal pelvis, Malignant neoplasm of bladder, unspecified, Peripheral T-cell lymphoma, not elsewhere classified, unspecified site, Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites, Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission, Chronic myeloid leukemia, BCR/ABL-positive, in relapse, Encounter for follow-up examination after completed treatment for malignant neoplasm, Personal history of malignant carcinoid tumor of large intestine, Personal history of other malignant neoplasm of large intestine, Personal history of malignant carcinoid tumor of rectum, Other epilepsy, not intractable, with status epilepticus, Other epilepsy, not intractable, without status epilepticus, Other epilepsy, intractable, with status epilepticus, Other epilepsy, intractable, without status epilepticus, Idiopathic chronic gout, unspecified site, without tophus (tophi), Idiopathic chronic gout, unspecified site, with tophus (tophi), Other secondary chronic gout, unspecified site, without tophus (tophi), Other secondary chronic gout, unspecified site, with tophus (tophi), Chronic gout, unspecified, without tophus (tophi), Chronic gout, unspecified, with tophus (tophi), Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues, Personal history of malignant neoplasm, unspecified, Personal history of immunosuppression therapy, Adverse effect of aminoglycosides, initial encounter, Adverse effect of inhaled anesthetics, initial encounter, Adverse effect of inhaled anesthetics, subsequent encounter, Adverse effect of inhaled anesthetics, sequela, Underdosing of inhaled anesthetics, initial encounter, Underdosing of inhaled anesthetics, subsequent encounter, Underdosing of inhaled anesthetics, sequela, Adverse effect of intravenous anesthetics, initial encounter, Adverse effect of intravenous anesthetics, subsequent encounter, Adverse effect of intravenous anesthetics, sequela, Underdosing of intravenous anesthetics, initial encounter, Underdosing of intravenous anesthetics, subsequent encounter, Underdosing of intravenous anesthetics, sequela, Subsequent ST elevation (STEMI) myocardial infarction of unspecified site, Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction, Saddle embolus of pulmonary artery with acute cor pulmonale, Other pulmonary embolism with acute cor pulmonale, Saddle embolus of pulmonary artery without acute cor pulmonale, Single subsegmental pulmonary embolism without acute cor pulmonale, Multiple subsegmental pulmonary emboli without acute cor pulmonale, Other pulmonary embolism without acute cor pulmonale, Intracardiac thrombosis, not elsewhere classified, Acute embolism and thrombosis of other specified veins, Chronic embolism and thrombosis of other specified veins, Embolism due to cardiac prosthetic devices, implants and grafts, initial encounter, Embolism due to cardiac prosthetic devices, implants and grafts, subsequent encounter, Embolism due to cardiac prosthetic devices, implants and grafts, sequela, Embolism due to vascular prosthetic devices, implants and grafts, initial encounter, Embolism due to vascular prosthetic devices, implants and grafts, subsequent encounter, Embolism due to vascular prosthetic devices, implants and grafts, sequela, Thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter, Thrombosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter, Thrombosis due to cardiac prosthetic devices, implants and grafts, sequela, Thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter, Thrombosis due to vascular prosthetic devices, implants and grafts, subsequent encounter, Thrombosis due to vascular prosthetic devices, implants and grafts, sequela, Long term (current) use of anticoagulants, Long term (current) use of antithrombotics/antiplatelets, Personal history of other venous thrombosis and embolism, Presence of other heart-valve replacement, Lambert-Eaton syndrome in disease classified elsewhere, Other intestinal Escherichia coli infections, Tuberculosis of nervous system, unspecified, Tuberculosis of genitourinary system, unspecified, Tuberculosis of other male genital organs, Tuberculous female pelvic inflammatory disease, Tuberculosis of other female genital organs, Tuberculosis of skin and subcutaneous tissue, Tuberculosis of digestive tract organs, not elsewhere classified, Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere, Otitis media, unspecified, unspecified ear, Pneumoconiosis due to other dust containing silica, Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage, Chronic or unspecified peptic ulcer, site unspecified, with perforation, Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation, Chronic peptic ulcer, site unspecified, without hemorrhage or perforation, Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation, Ulcerative colitis, unspecified, without complications, Ulcerative colitis, unspecified with other complication, Ulcerative colitis, unspecified with unspecified complications, Urinary tract infection, site not specified, Contact with and (suspected) exposure to tuberculosis, Contact with and (suspected) exposure to human immunodeficiency virus [HIV], Asymptomatic human immunodeficiency virus [HIV] infection status, Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx, Personal history of systemic steroid therapy, Some older versions have been archived.